Perspectives of US private payers on insurance coverage for pediatric and prenatal exome sequencing: Results of a study from the Program in Prenatal and Pediatric Genomic Sequencing (P3EGS)
- 10 September 2019
- journal article
- research article
- Published by Elsevier BV in Genetics in Medicine
- Vol. 22 (2), 283-291
- https://doi.org/10.1038/s41436-019-0650-7
Abstract
No abstract availableFunding Information
- National Human Genome Research Institute (U01HG009599)
- National Cancer Institute (R01CA221870)
This publication has 34 references indexed in Scilit:
- A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disordersGenetics in Medicine, 2016
- Clinical utility of genetic and genomic services: a position statement of the American College of Medical Genetics and GenomicsGenetics in Medicine, 2015
- Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findingsThe Lancet Respiratory Medicine, 2015
- Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disordersScience Translational Medicine, 2014
- The usefulness of whole-exome sequencing in routine clinical practiceGenetics in Medicine, 2014
- Overcoming the reimbursement barriers for clinical sequencing.JAMA, 2014
- Using the framework method for the analysis of qualitative data in multi-disciplinary health researchBMC Medical Research Methodology, 2013
- Living Without a Diagnosis: The Parental ExperienceGenetic Testing and Molecular Biomarkers, 2010
- Coverage Policy Development for Personalized Medicine: Private Payer Perspectives on Developing Policy for the 21-Gene AssayJournal of Oncology Practice, 2010
- Debating Clinical UtilityPublic Health Genomics, 2010